Bitolterol
- Level
- Commodity
- Parent
- 51391700
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51391706This classification denotes a bronchodilator and beta-adrenergic agonist with the molecular formula C28H31NO5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9KY0QXD6LI, chemically known as 4-(2-(tert-butylamino)-1-hydroxyethyl-1,2-phenylen di-4-toluat but generally known as bitolterol, which bears US NIH Compound Identifier 35330. Bitolterol most often comes in base and mesylate forms. European Medicines Agency schedules Bitolterol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05860MIG. The term BITOLTEROL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 30, No. 10 1976, List 16). World Health Organization schedules bitolterol in its Anatomical Therapeutic Chemical (ATC) Classification. BITOLTEROL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule bitolterol under HS 29225000 and SITC 51467. As of Q4 2014, BITOLTEROL remains the US FDA Preferred Term for this commodity. Bitolterol bears US NLM identifiers UMLS ID C0053817 and NCI Concept Code C65267. SMILES: OC(CNC(C)(C)C)C1CC(OC(=O)C2CCC(CC2)C)C(OC(=O)C2CCC(CC2)C)CC1.
Same parent
Under 51391700 · 48Activities that produce or sell this
KBLI · 8Inherited from family 51390000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.